source · application/json
source_9e92981d1f6d4779
sha256 8a04ad15d933406fd53588e3db6a38762b1104839387ceec6e093589746d1a23
by researka:v2 · 2026-06-02 09:18:44.156787+04:00
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "ab40c73a-dca5-4102-8b82-441a90f13b37", "sources": [{"directness": "primary", "doi": "10.1002/ijc.31783", "risk_of_bias": "not appraised in public sidecar", "study": "Use of metformin and survival of patients with high‐grade glioma"}, {"directness": "primary", "doi": "10.3389/fmed.2021.640785", "risk_of_bias": "not appraised in public sidecar", "study": "Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study"}, {"directness": "review-level", "doi": "10.3389/fmed.2021.704666", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis"}, {"directness": "review-level", "doi": "10.1016/j.aohep.2019.10.005", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review"}, {"directness": "primary", "doi": "10.1111/acel.12496", "risk_of_bias": "not appraised in public sidecar", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer"}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "ab40c73a-dca5-4102-8b82-441a90f13b37",
"researka_submission_id": "e2c7fc40-0c68-47c0-805b-b56bc538ee9f",
"sidecar_name": "risk_of_bias.json",
"sidecar_url": "https://api.researka.org/publications/ab40c73a-dca5-4102-8b82-441a90f13b37/sidecars/risk_of_bias.json"
}